MedTrace Logo

Identification of Plasma miRNAs as Potential Biomarkers in Asthma Exacerbation

NCT01631760 · Status: WITHDRAWN · Type: OBSERVATIONAL

Last updated 2014-10-07

No results posted yet for this study

Summary

We hypothesize that there is a statistically significant difference in miRNA profiling and expression of subjects with asthma upon its exacerbation compared to patient's baseline level or following effective treatment of an exacerbation of asthma. Therefore, plasma miRNA profiling may provide noninvasive, highly specific and sensitive biomarkers for asthma exacerbation's detection and treatment follow-up.

Conditions

Interventions

GENETIC

no intervention

We will be analyzing MicroRNA in subjects with Asthma Exacerbations by various age groups, Ages 5-12yrs, 13-55yrs, and 56-85yrs for genetic similarities and differences.

Sponsors & Collaborators

  • University of South Florida

    lead OTHER

Principal Investigators

  • Richard Lockey, MD · Division of Allergy and Immunology, Department of Internal Medicine, University of South Florida College of Medicine

Eligibility

Min Age
5 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-10-31
Primary Completion
2014-02-28

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01631760 on ClinicalTrials.gov